The 23.56% Simple Moving Average of HCA Healthcare Inc’s (HCA) Stock in the Past 200 Days

The stock of HCA Healthcare Inc (HCA) has seen a 2.54% increase in the past week, with a 10.88% gain in the past month, and a 19.77% flourish in the past quarter. The volatility ratio for the week is 1.26%, and the volatility levels for the past 30 days are at 2.01% for HCA. The simple moving average for the last 20 days is 5.04% for HCA’s stock, with a simple moving average of 23.56% for the last 200 days.

Is It Worth Investing in HCA Healthcare Inc (NYSE: HCA) Right Now?

The price-to-earnings ratio for HCA Healthcare Inc (NYSE: HCA) is above average at 17.89x, Company’s 36-month beta value is 1.67.Analysts have differing opinions on the stock, with 10 analysts rating it as a “buy,” 6 as “overweight,” 6 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for HCA is 185.44M, and currently, short sellers hold a 1.38% ratio of that floaft. The average trading volume of HCA on August 22, 2024 was 1.23M shares.

HCA) stock’s latest price update

HCA Healthcare Inc (NYSE: HCA)’s stock price has gone rise by 1.24 in comparison to its previous close of 376.67, however, the company has experienced a 2.54% increase in its stock price over the last five trading days. zacks.com reported 2024-08-21 that HCA Healthcare (HCA), Royal Caribbean Cruises (RCL) and General Motors (GM) can make the most of the promising period surrounding the Jackson Hole gathering.

Analysts’ Opinion of HCA

Many brokerage firms have already submitted their reports for HCA stocks, with Robert W. Baird repeating the rating for HCA by listing it as a “Outperform.” The predicted price for HCA in the upcoming period, according to Robert W. Baird is $396 based on the research report published on May 30, 2024 of the current year 2024.

Barclays, on the other hand, stated in their research note that they expect to see HCA reach a price target of $356. The rating they have provided for HCA stocks is “Overweight” according to the report published on March 06th, 2024.

Bernstein gave a rating of “Mkt Perform” to HCA, setting the target price at $301 in the report published on January 04th of the current year.

HCA Trading at 11.24% from the 50-Day Moving Average

After a stumble in the market that brought HCA to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 0.48% of gains for the given period.

Volatility was left at 2.01%, however, over the last 30 days, the volatility rate increased by 1.26%, as shares surge +7.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.18% upper at present.

During the last 5 trading sessions, HCA rose by +2.35%, which changed the moving average for the period of 200-days by +64.89% in comparison to the 20-day moving average, which settled at $364.43. In addition, HCA Healthcare Inc saw 40.88% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at HCA starting from Whalen Kathleen M, who sale 2,987 shares at the price of $363.51 back on Jul 31 ’24. After this action, Whalen Kathleen M now owns 9,454 shares of HCA Healthcare Inc, valued at $1,085,804 using the latest closing price.

Whalen Kathleen M, the SVP & Chief Ethics Officer of HCA Healthcare Inc, sale 1,864 shares at $359.92 during a trade that took place back on Jul 29 ’24, which means that Whalen Kathleen M is holding 12,441 shares at $670,891 based on the most recent closing price.

Stock Fundamentals for HCA

Current profitability levels for the company are sitting at:

  • 0.15 for the present operating margin
  • 0.49 for the gross margin

The net margin for HCA Healthcare Inc stands at 0.08. The total capital return value is set at 0.24.

Based on HCA Healthcare Inc (HCA), the company’s capital structure generated 1.04 points at debt to capital in total, while cash flow to debt ratio is standing at 0.23. The debt to equity ratio resting at -25.55. The interest coverage ratio of the stock is 5.12.

Currently, EBITDA for the company is 12.73 billion with net debt to EBITDA at 3.13. When we switch over and look at the enterprise to sales, we see a ratio of 2.05. The receivables turnover for the company is 6.68for trailing twelve months and the total asset turnover is 1.19. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.06.

Conclusion

In a nutshell, HCA Healthcare Inc (HCA) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Most Popular

Related Posts